RETRACTED: Fasciola hepatica excretory-secretory products attenuate demyelination and reduce neuroinflammation in the Cuprizone –induced multiple sclerosis model
PLOS One · 05.06.2026 · 21 (6) · e0349675
DOI: 10.1371/journal.pone.0349675 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift PLOS One, online erschienen am 05.06.2026. Verfasst von Aliakbar Mariki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran. Hauptthemen laut MEDLINE: Multiple Sclerosis, Fasciola hepatica, Demyelinating Diseases, Neuroinflammatory Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Multiple sclerosis (MS) is characterized by chronic neuroinflammation and progressive demyelination, with current therapies failing to adequately address both processes simultaneously. Helminth-derived excretory–secretory products (ESP) are immunomodulatory molecules that suppress host inflammation and are promising candidates for MS treatment. However, their capacity to promote remyelination remains poorly understood. This study investigated the effects of Fasciola hepatica ESP in the cuprizone-induced demyelination model. Male C57BL/6 mice were divided into four groups: control (CON), control + FES (CON + FES), cuprizone (CUP), and cuprizone + FES (CUP + FES). FES was administered intraperitoneally during the demyelination phase. Motor and cognitive functions were evaluated using open field, rotarod, wire grip, and shuttle box tests. Neuroinflammation was assessed by measuring TNF and IL-1β levels, while myelin-related changes were evaluated by MBP and Olig2 expression (ELISA and qPCR) and Luxol Fast Blue staining. FES treatment significantly reduced pro-inflammatory cytokines, increased MBP and Olig2 levels, improved myelin integrity, and enhanced motor and cognitive performance compared to untreated cuprizone mice, though full recovery to control levels was not achieved. These findings demonstrate that FES attenuates neuroinflammation and is associated with partial improvements in myelin-related outcomes in the cuprizone model, supporting the therapeutic potential of helminth-derived molecules for MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
- Department of Drug Design and Pharmacology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
- Research Center for Hydatid Disease in Iran, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
- Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.
- Cognitive Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
ORCID-Profile: Mohammad Shabani
Zitieren
APA
Mariki, A., Kohlmeier, K. A., Mousavi, S. M., Keyhani, A., Harandi, M. F., Sabzalizadeh, M., & Shabani, M. (2026). RETRACTED: Fasciola hepatica excretory-secretory products attenuate demyelination and reduce neuroinflammation in the Cuprizone –induced multiple sclerosis model. PLOS One, 21(6), e0349675. https://doi.org/10.1371/journal.pone.0349675
Vancouver
Mariki A, Kohlmeier KA, Mousavi SM, Keyhani A, Harandi MF, Sabzalizadeh M, et al. RETRACTED: Fasciola hepatica excretory-secretory products attenuate demyelination and reduce neuroinflammation in the Cuprizone –induced multiple sclerosis model. PLOS One. 2026;21(6):e0349675. doi:10.1371/journal.pone.0349675
BibTeX
@article{Mariki2026,
author = {Mariki, Aliakbar and Kohlmeier, Kristi Anne and Mousavi, Seyed Mohammad and Keyhani, Alireza and Harandi, Majid Fasihi and Sabzalizadeh, Mansoureh and Shabani, Mohammad},
title = {RETRACTED: Fasciola hepatica excretory-secretory products attenuate demyelination and reduce neuroinflammation in the Cuprizone –induced multiple sclerosis model},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {6},
pages = {e0349675},
doi = {10.1371/journal.pone.0349675}
}
EUVIMED